1Watchko JF,Kaplan M,Stark AR,et al.Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States?[J].J Perinatol,2013,33(7):499.
2Kaplan M,Bromiker R,Hammerman C.Severe neonatal hyperbilirubinemia and kernicterus:are these still problems in the third millennium?[J].Neonatology,2011,100(4):354.
3Brown SE,Guzelian CP,Schuetz E,et al.Critical role of extracellular matrix on induction by phenobarbital of cytochrome P450 2B1/2 in primary cultures of adult rat hepatocytes[J].Lab Invest,1995,73(6):818.
4Trevett TN Jr,Dorman K,Lamvu G,et al.Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn[J].Am J Obstet Gynecol,2005,192(2):478.
5Rubaltelli FF,Griffith PF.Management of neonatal hyperbilirubinaemia and prevention of kernicterus[J].Drugs,1992,43(6):864.
6Christensen RD,Yaish HM,Wiedmeier SE,et al.Neonatal death suspected to be from sepsis was found to be kernicterus with G6PD deficiency[J].Pediatrics,2013,132(6):e1694.
7Kishore Kumar R,Nagar N,Ranieri E.Newborn Screening for G6PD Deficiency-Why is it Important for India?[J].Indian J Pediatr,2014,81(1):90.
